Avalyn Pharma annual free cash flow
2024
2025
Avalyn Pharma Free Cash Flow (FCF) History (AVLN)
Avalyn Pharma reported −$81.8M in free cash flow for fiscal 2025, a decrease of $33.4M from the previous fiscal year.
View full Avalyn Pharma company overviewAvalyn Pharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$81.8M | −$33.4M | — | — |
| 2024 | 2024-12-31 | −$48.5M | — | — | — |
Avalyn Pharma quarterly free cash flow
Q1.26
Q2.26
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | −$26.3M | −$5.6M | — | — |
| Q1 2026 · Mar 31 | 2026-03-31 | −$30.2M | −$10.9M | — | — |
| Q2 2026 · Jun 30 | 2025-06-30 | −$20.7M | — | — | — |
| Q1 2026 · Mar 31 | 2025-03-31 | −$19.3M | — | — | — |
Avalyn Pharma free cash flow growth trends
Avalyn Pharma's latest reported quarter, Q2 2026 · Jun 30, generated −$26.3M in free cash flow, a decrease of $5.6M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Avalyn Pharma source filings ↗